Emblation Partners With DermLite to Expand Access to Dermoscopy for Podiatrists

Key Takeaways

• Emblation has partnered with DermLite to make the DermLite DL1 dermatoscope available through the Swift store.
• The collaboration complements Emblation's recently launched Swiftscope lesion-tracking app, which integrates digital dermoscopy and smartphone imaging for SwiftPro users.
• The companies say the partnership is intended to improve diagnostic capabilities, treatment monitoring, and patient education in podiatry practices.

Emblation has announced a new collaboration with DermLite that will make the DermLite DL1 dermatoscope available through the Swift store, expanding access to dermoscopy tools for podiatrists using the company's Swift microwave therapy platform.

The partnership aligns with growing adoption of dermoscopy beyond dermatology, particularly in podiatry, where clinicians increasingly use the technology to evaluate skin lesions, support differential diagnosis, and document treatment response. Dermatoscopes provide enhanced visualization of skin structures, helping clinicians distinguish between lesion types and monitor changes over time.

Swiftscope Integration Aims to Enhance Lesion Monitoring

The announcement follows Emblation's recent launch of Swiftscope, a lesion-tracking application developed for SwiftPro users. The app combines digital dermoscopy with smartphone technology to capture comparative images, establish baseline documentation, and monitor lesion progression throughout treatment.

"Emblation has recently introduced Swiftscope, a lesion tracking app designed specifically for SwiftPro users. Swiftscope integrates digital dermoscopy and smartphone technology to support comparative imaging, establish visual baselines, and monitor treatment progress over time," said Ian Stevens, CEO of Emblation. "The partnership with DermLite reflects our shared commitment to equipping healthcare professionals with practical, high-quality tools that improve outcomes and elevate the patient experience."

Stevens added: "By combining DermLite's dedication to diagnostic excellence with Emblation's commitment to innovation we hope to expand access to dermoscopy and support clinicians' commitment to improving standards of care."

The companies said the collaboration is designed to provide clinicians with streamlined access to dermoscopy technology while supporting clinical decision-making and patient communication during lesion assessment and follow-up.